[A rapid colorimetric assay for viability of osteosarcoma cells after chemotherapy]
- PMID: 20034909
[A rapid colorimetric assay for viability of osteosarcoma cells after chemotherapy]
Abstract
Objective: To introduce a rapid colorimetric method for assessing the viability of osteosarcoma cells after chemotherapy.
Methods: Colorimetric assay and automatic microplate scanning spectrophotometer were used for assaying the viability of osteosarcoma cells.
Results: Close correlation was found between the absorbance at 570 nm of the formazan products and the number of viable osteosarcoma cells.
Conclusion: An effective, sensitive and convenient colorimetric assay has been established to assess the survival of osteosarcoma cells following chemotherapy.
Similar articles
-
Osteosarcoma. Specimen management following primary chemotherapy.Hematol Oncol Clin North Am. 1995 Aug;9(4):841-67. Hematol Oncol Clin North Am. 1995. PMID: 7490245 Review.
-
[Determination of the degree of morphological regression following chemotherapy in malignant bone tumors].Pathologe. 1983 May;4(3):135-41. Pathologe. 1983. PMID: 6576329 German. No abstract available.
-
[Osteogenic osteosarcoma and drug therapy. Study in vitro of osteosarcoma's sensitivity to drugs. Therapeutic applications].Chirurgie. 1970;96(1):53-62. Chirurgie. 1970. PMID: 5279883 French. No abstract available.
-
Growth inhibition of rat osteosarcoma and malignant fibrous histiocytoma cells by tyrosine kinase inhibitor STI571.In Vivo. 2003 May-Jun;17(3):255-8. In Vivo. 2003. PMID: 12929576
-
[Role of chemotherapy in treatment of osteosarcoma].Pediatr Pol. 1995 Nov;70(11):939-47. Pediatr Pol. 1995. PMID: 8677160 Review. Polish.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical